Fate Therapeutics, Inc. (FATE) Earnings
NASDAQ·Healthcare·Biotechnology
$2.31
-0.43%
Mkt Cap $269.25M
EPS — Estimate vs Actual
Mkt Cap
$269.25M
P/E
—
Fwd P/E
—
P/S
44.66
Rev TTM
—
EPS TTM
-$1.09
NASDAQ·Healthcare·Biotechnology
$2.31
-0.43%
Mkt Cap $269.25M
Mkt Cap
$269.25M
P/E
—
Fwd P/E
—
P/S
44.66
Rev TTM
—
EPS TTM
-$1.09